arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2406.04852cond-mat.soft
收藏

黄芩素对阿尔茨海默病淀粉样β蛋白原纤维的去稳定化作用:来自全原子分子动力学模拟的机制见解

Destabilization of Alzheimers Amyloid-beta Protofibrils by Bai-calein: Mechanistic Insights from All-atom Molecular Dynamics Simulations

Sadika Choudhury, Ashok Kumar Dasmahapatra

AI总结:

本文通过全原子分子动力学模拟研究天然类黄酮黄芩素(BCL)对Aβ原纤维的去稳定化机制,发现BCL通过竞争疏水接触、破坏盐桥和氢键降低原纤维结构稳定性,表明其可作为治疗阿尔茨海默病的潜在药物。

摘要:

阿尔茨海默病(AD)是一种神经退行性疾病,是痴呆症最常见的形式,也是全球第五大死亡原因。神经毒性Aβ纤维在脑神经组织中的聚集和沉积是AD发病机制中的关键标志。利用各种天然分子对淀粉样肽进行去稳定化研究具有极其重要的意义,因为这些分子具有作为AD神经保护和治疗剂的巨大潜力。我们对淀粉样蛋白原丝中间体的U形五聚体进行了分子动力学(MD)模拟,以研究在黄芩素(BCL)——一种天然存在的类黄酮——存在下的去稳定化机制。我们发现BCL分子与原纤维的非极性残基形成了强疏水接触。结合后,它与Aβ蛋白自身的天然疏水接触发生竞争。BCL通过破坏链间盐桥和氢键,使原纤维疏水核心的紧密堆积变得松散。Aβ原纤维结构稳定性的降低通过均方根偏差(RMSD)、回转半径和溶剂可及表面积(SASA)的增加以及β-折叠含量的减少得到证实。主成分分析(PCA)表明,BCL分子的存在加剧了原纤维的运动,尤其影响A链和B链区域的残基。我们的研究结果表明,BCL将是Aβ原丝的一种有效去稳定剂,并可能被视为治疗AD的治疗剂。

英文摘要:

Alzheimer's disease (AD) is a neurodegenerative disorder; it is the most common form of de-mentia and the fifth leading cause of death globally. Aggregation and deposition of neurotoxic A-beta fibrils in the neural tissues of the brain is a key hallmark in the pathogenesis of AD. Desta-bilisation studies of the amyloid-peptide by various natural molecules are of the utmost rele-vance due to their enormous potential as neuroprotective and therapeutic agents for AD. We performed molecular dynamics (MD) simulation on the U-shaped pentamers of amyloidogenic protofilament intermediates to investigate the destabilisation mechanism in the presence of Bai-calein (BCL), a naturally occurring flavonoid. We found that the BCL molecule formed strong hydrophobic contacts with non-polar residues of the protofibril. Upon binding, it competed with the native hydrophobic contacts of the A-beta protein. BCL loosened the tight packing of the hydrophobic core of the protofibril by disrupting the inter-chain salt bridges and hydrogen bonds. The decrease in the structural stability of A-beta protofibrils was confirmed through the en-hanced root mean square deviation (RMSD), radius of gyration and solvent accessible surface area (SASA), and reduced beta-sheet content. PCA indicated that the presence of the BCL mole-cule intensified protofibril motions, particularly affecting residues in Chain A and B regions. Our findings propose that BCL would be a potent destabiliser of A-beta protofilament, and may be considered as a therapeutic agent in treating AD.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑